Stratec (ETR:SBS) Stock Price Crosses Above 50 Day Moving Average – Should You Sell?

Stratec SE (ETR:SBS – Get Free Report)’s share price crossed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of €23.38 and traded as high as €24.15. Stratec shares last traded at €23.95, with a volume of 40,413 shares trading hands.

Stratec Trading Up 4.4%

The stock’s fifty day simple moving average is €23.38 and its 200-day simple moving average is €20.24. The company has a debt-to-equity ratio of 48.53, a current ratio of 4.23 and a quick ratio of 1.65. The firm has a market cap of $300.34 million, a PE ratio of 30.00, a PEG ratio of 10.43 and a beta of 0.84.

Stratec Company Profile

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.

Further Reading

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.